TRVI · NASDAQ
Trevi Therapeutics (TRVI) Stock Price & Fundamentals
Trevi Therapeutics (TRVI) closed at $216.32 on Oct 9, 2026, up 1.16% from the previous close of $213.84.
Share price, past year
1Y −16.93%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $216.32 |
| Sep 30, 2026 | $212.68 |
| Aug 31, 2026 | $210.31 |
| Jul 31, 2026 | $209.72 |
| Jun 30, 2026 | $210.95 |
| May 29, 2026 | $207.99 |
| Apr 30, 2026 | $213.99 |
| Mar 31, 2026 | $210.67 |
| Feb 27, 2026 | $220.32 |
| Jan 30, 2026 | $226.75 |
| Dec 31, 2025 | $246.68 |
| Nov 28, 2025 | $246.30 |
| Oct 31, 2025 | $257.97 |
Key statistics
- Market cap
- $30.81B
- EPS (TTM)
- −$0.34
- Net income (TTM)
- −$51.11M
- Shares outstanding
- 142.4M
- 52-week range
- $201.28 – $266.68
Trevi Therapeutics's market cap is $30.81B, based on a share price of $216.32 and 142.4M shares outstanding as of Jun 30, 2026.
Financials
Trevi Therapeutics's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Trevi Therapeutics reported a net loss of $42.76M in fiscal 2025.
Company profile
- Name
- Trevi Therapeutics, Inc.
- Ticker
- TRVI
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 195 Church Street, 16th Floor, New Haven, CT 06510
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001563880
Recent SEC filings
- Aug 6, 2026
- Aug 6, 2026
- Jun 4, 2026
- May 5, 2026
- May 5, 2026
- Apr 17, 2026
- Mar 17, 2026
- Mar 17, 2026
Frequently asked questions
What is Trevi Therapeutics's stock price?
Trevi Therapeutics (TRVI) closed at $216.32 on Oct 9, 2026, up 1.16% from the previous close of $213.84.
What is Trevi Therapeutics's market cap?
Trevi Therapeutics's market cap is $30.81B, based on a share price of $216.32 and 142.4M shares outstanding as of Jun 30, 2026.
Does Trevi Therapeutics pay a dividend?
Trevi Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Trevi Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures